TY - JOUR TI - One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study AU - Lu, Jing AU - Shen, Shan-mei AU - Ling, Qing AU - Wang, Bin AU - Li, Li-rong AU - Zhang, Wei AU - Qu, Duo-duo AU - Bi, Yan AU - Zhu, Da-long T2 - Stem Cell Research & Therapy AB - The preservation or restoration of β cell function in type 1 diabetes (T1D) remains as an attractive and challengeable therapeutic target. Mesenchymal stromal cells (MSCs) are multipotent cells with high capacity of immunoregulation, which emerged as a promising cell-based therapy for many immune disorders. The objective of this study was to examine the efficacy and safety of one repeated transplantation of allogeneic MSCs in individuals with T1D. DA - 2021/06/10/ PY - 2021 DO - 10.1186/s13287-021-02417-3 DP - BioMed Central VL - 12 IS - 1 SP - 340 J2 - Stem Cell Research & Therapy SN - 1757-6512 ST - One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes UR - https://doi.org/10.1186/s13287-021-02417-3 Y2 - 2021/06/18/21:48:43 KW - Mesenchymal stromal cells KW - Transplantation KW - Type 1 diabetes KW - β cell function ER -